Abstract
This study suggests that late HIV diagnosis (LD) may contribute to brain injury, endocrine disruption, and immune dysregulation in HIV-positive men who have sex with men (MSM). Consequently, there is an urgent need to develop public health strategies targeting late diagnosis, with a focus on strengthening screening and early detection for high-risk populations, as well as monitoring brain injury, endocrine, and immune functions in individuals with LD, and formulating precise, individualized intervention strategies to reduce the long-term impact of LD on the health of HIV-positive MSM.
Introduction
Published in Frontiers in Immunology, this research explores the systemic "biological debt" incurred by individuals who receive a late HIV diagnosis (LD). By examining the intersection of neurology, endocrinology, and immunology, the authors demonstrate that delayed treatment triggers a cascade of damage that persists even after antiretroviral therapy (ART) begins.
The Problem: The Hidden Impact of Late Diagnosis
Despite the widespread availability of ART, late HIV diagnosis remains a significant public health challenge. While LD is known to lead to higher mortality, its "hidden" impact on the brain-endocrine-immune axis is less understood. This study investigated how the duration of untreated infection affects brain integrity, hormone regulation (the HPA axis), and immune cell functionality, specifically within the MSM population.
Methodology
The researchers conducted a cross-sectional study of 72 MSM participants, divided into Late Diagnosis (LD, $n=38$) and non-LD ($n=34$) groups. The study employed a multimodal approach:
- Neuroimaging: 1.5T MRI was used for Voxel-Based Morphometry (VBM) and resting-state fMRI (rs-fMRI) to assess brain structure and functional connectivity.
- Endocrine Profiling: Plasma concentrations of cortisol, ACTH, and CRH were measured via ELISA.
- High-Dimensional Immunology: Mass Cytometry (CyTOF) mapped T-cell subpopulations with high resolution.
Structural Brain Atrophy
The LD group exhibited significant structural changes compared to the non-LD group. Specifically, LD participants showed lower total gray matter volume (GMV), with marked reductions in regions such as the right supplementary motor area, left superior occipital gyrus, and left supramarginal gyrus.
The atrophy in the left supramarginal gyrus—a region critical for language processing—correlated directly with lower cognitive scores on the Montreal Cognitive Assessment (MoCA).
Volumetric and Hormonal Findings
Statistical analysis revealed that LD was associated with significant decreases in Total Intracranial Volume (TIV) and Gray Matter Volume (GMV) compared to the non-LD group.
Beyond structural changes, LD individuals exhibited significantly higher cortisol levels. This suggests that the prolonged inflammatory state of untreated HIV dysregulates the hypothalamic-pituitary-adrenal (HPA) axis, maintaining a state of physiological stress that may further damage hippocampal neurons.
Immune Exhaustion and Systemic Interaction
The study identified a specific depletion of central memory T cells ($T_{CM}$) in the LD group, suggesting a compromised ability to mount secondary immune responses. Furthermore, elevated perforin expression in double-negative T cells (DNTs) indicated a shift toward a cytotoxic profile, potentially contributing to chronic neuroinflammation.
A significant "interaction effect" was also observed: LD patients with comorbid neuropsychiatric disorders (like depression or anxiety) showed more pronounced brain activity alterations and higher cortisol levels, suggesting that mental health and HIV timing are biologically intertwined.
Conclusion and Future Directions
The findings highlight that LD creates a lasting imprint on the body’s regulatory systems. While the study's cross-sectional nature and sample size are limitations, the results underscore the need for routine monitoring of cortisol and neuroimaging in HIV care. Future public health strategies must prioritize early detection and personalized interventions to mitigate the long-term physiological impact of late diagnosis.
Summary updated